Anti-cancer Potential of Bioactive Compounds from Moringa oleifera against PARK2 in Oral Cancer protein: In silico Approach
Anti-cancer Potential of Bioactive Compounds from Moringa oleifera
DOI:
https://doi.org/10.70066/jahm.v12i1.1246Keywords:
: Bioactive compound, molecular docking, Moringa oleifera, oral cancer, PARK2, ADMEAbstract
Background: Globally, oral cancer (OC) is one of the most common cancers and it is the second highest incidence in India. Medicinal plants are well known anticancer therapeutic agents since ages and considered alternative treatment of cancer diseases. Moringa oleifera, the most crucial medicinal plant contains a vast number of potential anti-cancer bioactive compounds. Objective: The aim of the current study is to investigate the therapeutic potential of five bioactive compounds kaempferol, niazimicin, niazinin, O-ethyl-4-(alpha-l-rhamnosyloxy) benzyl carbamate and quercetin of Moringa oleifera target PARK2 against OC proliferation via in silico study. Methodology: In silico approach via ADME/ProTox-II tools and molecular docking analysis have assessed to find binding affinity between PARK2 and Moringa oleifera selected compounds. Results: Our finding revealed that Kaempferol, bioactive compounds of Moringa oleifera shows Lipinski's Five Rules and is non-toxic to the liver. Besides, it also displays higher binding affinity -7.2kcal/mol and a lower binding energy followed by five selected compounds and also from 5-Flurouracil with the PARK2 interaction. Conclusion: The study provided insight into Kaempferol's possibilities of success as drug discovery candidates in the face of PARK2-related OC regulation. Thus, future in vitro, in vivo, and clinical studies are required to corroborate our findings.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dr. Siya Ram Siya Ram

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.